Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Chronic Heart Failure

Free Subscription 01.12.2025 1 Am J Cardiol 2 Cardiovasc Res 1 Circ Heart Fail 3 Eur Heart J 2 Eur J Heart Fail 3 Int J Cardiol 2 J Am Coll Cardiol 2 J Card Fail 1 J Cardiol 1 Lancet 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. SPINETTA LE, Heid CA
   One Ring to Rule Them All: A Commentary on "Impacts of Mitral Annular Calcification on Heart Failure with Preserved Ejection Fraction".
   Am J Cardiol. 2025 Nov 26:S0002-9149(25)00689.
   PubMed        
   
   

   
   Cardiovasc Res

2. HE M, Tay WT, Song N, Liu T, et al
   Cardioprotective role of RBFox1 in myocardial infarction-induced heart failure.
   Cardiovasc Res. 2025 Nov 26:cvaf206. doi: 10.1093.
   PubMed         Abstract available
   
   
3. ADRAH Y, Hegemann N, Faidel D, Kucherenko MM, et al
   Defining HFpEF in rodents: a systematic review.
   Cardiovasc Res. 2025;121:2134-2143.
   PubMed         Abstract available
   
   

   
   Circ Heart Fail

4. PARK A, Andargie TE, Tian X, Keller M, et al
   Cell-Free DNA Profiles End-Organ Injury and Predicts Outcomes in Advanced Heart Failure With Left Ventricular Assist Device Implantation.
   Circ Heart Fail. 2025 Nov 27:e013302. doi: 10.1161/CIRCHEARTFAILURE.124.013302.
   PubMed         Abstract available
   
   

   
   Eur Heart J

5. CANNATA A, Packer M
   Vericiguat in heart failure with reduced ejection fraction: being confident in the face of uncertainty.
   Eur Heart J. 2025 Nov 28:ehaf888. doi: 10.1093.
   PubMed        
   
   
6. SCHOMMER N, Gendron N, Krauel K, Van Bruggen S, et al
   Neutrophil extracellular traps and peptidylarginine deiminase 4-mediated inflammasome activation link diabetes to cardiorenal injury and heart failure.
   Eur Heart J. 2025 Nov 27:ehaf963. doi: 10.1093.
   PubMed         Abstract available
   
   
7. VAN LINTHOUT S, Matz I, Gonzalez A, Davis J, et al
   Cardiac fibroblasts in myocardial injury and heart failure.
   Eur Heart J. 2025 Nov 25:ehaf902. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Eur J Heart Fail

8. PANDEY A, Moroney M, Verma S, Borlaug BA, et al
   Effects of semaglutide in obesity-related heart failure with preserved ejection fraction across the age spectrum: Findings from the STEP-HFpEF programme.
   Eur J Heart Fail. 2025 Nov 25. doi: 10.1002/ejhf.70049.
   PubMed         Abstract available
   
   
9. MONZO L, Savarese G, Mullens W, Abdin A, et al
   Pharmacological treatment for patients with obesity and heart failure: Focus on glucagon-like peptide-1 receptor agonists. European Journal of Heart Failure expert consensus document.
   Eur J Heart Fail. 2025 Nov 27. doi: 10.1002/ejhf.70082.
   PubMed         Abstract available
   
   

   
   Int J Cardiol

10. PELLICORI P, Rastogi T, Palazzuoli A, Ruocco G, et al
    Systemic and pulmonary congestion by ultrasound and prognosis in heart failure: A pooled cohort analysis.
    Int J Cardiol. 2025;445:134033.
    PubMed         Abstract available
    
    
11. CHEN X, Zhang X, Yang M, Shan C, et al
    The influence of non-cardiac comorbidities burden on heart failure with improved ejection fraction: Evaluated by Charlson comorbidity index.
    Int J Cardiol. 2025 Nov 26:134063. doi: 10.1016/j.ijcard.2025.134063.
    PubMed         Abstract available
    
    
12. TAKAHAMA H, Nochioka K, Miyata S, Hayashi H, et al
    Association of Body Mass Index with ten-year outcomes in asymptomatic stage a/B heart failure patients: Insights from the CHART-2 study.
    Int J Cardiol. 2025 Nov 26:134062. doi: 10.1016/j.ijcard.2025.134062.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

13. SAYED A, Vasan RS, Harrell FE Jr, Butler J, et al
    Trends in the Prevalence, Associated Risk Factors, and Health Burden of Heart Failure in the United States, 1988 to 2023.
    J Am Coll Cardiol. 2025 Nov 5:S0735-1097(25)09311.
    PubMed         Abstract available
    
    
14. OSTROMINSKI JW, Givertz MM
    Designing Trials in an Era of Shifting Heart Failure Phenotypes: A Focus on Prevention to Achieve Success.
    J Am Coll Cardiol. 2025 Nov 19:S0735-1097(25)09987.
    PubMed        
    
    

    
    J Card Fail

15. FRANCO LA, Zhang A, Garan AR
    Have We Been Overlooking Lipoprotein(a) in Heart Failure?
    J Card Fail. 2025 Nov 24:S1071-9164(25)01022.
    PubMed        
    
    
16. BASILE C, Merolla A, Mancusi C, Ambrosino P, et al
    Time-to-first clinical benefit of glucagon-like peptide-1 receptor agonists in heart failure.
    J Card Fail. 2025 Nov 20:S1071-9164(25)01027.
    PubMed        
    
    

    
    J Cardiol

17. KANAI M, Yazaki K, Ejima K, Kataoka S, et al
    Prognostic Comparison of Improved versus Preserved Left Ventricular Systolic Function Following Atrial Fibrillation Ablation in Heart Failure Patients.
    J Cardiol. 2025 Nov 20:S0914-5087(25)00281-3. doi: 10.1016/j.jjcc.2025.
    PubMed         Abstract available
    
    

    
    Lancet

18. SLIWA K, Hilfiker-Kleiner D, Damasceno A, Al Farhan H, et al
    Peripartum cardiomyopathy.
    Lancet. 2025;406:2483-2493.
    PubMed         Abstract available
    
    

    
    PLoS One

19. PETER-MARSKE KM, Howard AG, Evenson KR, Berkeley SJ, et al
    The associations of premorbid social isolation and social support with self-rated health and heart failure outcomes in the atherosclerosis risk in communities (ARIC) Study.
    PLoS One. 2025;20:e0337517.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.